ArticleFrontiers in oncology2021

Targeting miR-185-3p Inhibits Head and Neck Squamous Cell Carcinoma by Modulating RAB25.

Xueping Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.